AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹4.93 Cr | ₹5.68 Cr | ₹11 Cr | ₹47 Cr | ₹29 Cr |
What is the latest Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹4.93 Cr |
| Mar2025 | ₹5.68 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹47 Cr |
| Mar2022 | ₹29 Cr |
How is Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.93 Cr | -13.20 | |
| Mar2025 | ₹5.68 Cr | -50.37 | |
| Mar2024 | ₹11 Cr | -75.76 | |
| Mar2023 | ₹47 Cr | 60.86 | |
| Mar2022 | ₹29 Cr | - | |
Compare Consolidated Net Profit of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹266.6 Cr | -1.7% | -11.9% | 7.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -1.7% |
-11.9% |
7.5% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses